{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:43:26Z","timestamp":1790707406328,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/mp.2013.165","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T08:57:41Z","timestamp":1386665861000},"page":"1258-1266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain"],"prefix":"10.1038","volume":"19","author":[{"given":"S S","family":"Kaalund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E N","family":"Newburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Deep-Soboslay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D R","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B K","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"BFmp2013165_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH . Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192: 481\u2013483.","journal-title":"Science"},{"key":"BFmp2013165_CR2","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.1145194","volume":"188","author":"P Seeman","year":"1975","unstructured":"Seeman P, Lee T . Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975; 188: 1217\u20131219.","journal-title":"Science"},{"key":"BFmp2013165_CR3","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235\u20139240.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR4","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1523\/JNEUROSCI.0805-07.2007","volume":"27","author":"Y Kumakura","year":"2007","unstructured":"Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa\/positron emission tomography study. J Neurosci 2007; 27: 8080\u20138087.","journal-title":"J Neurosci"},{"key":"BFmp2013165_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","volume":"346","author":"J Hietala","year":"1995","unstructured":"Hietala J, Syv\u00e4lahti E, Vuorio K, R\u00e4kk\u00f6l\u00e4inen V, Bergman J, Haaparanta M et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346: 1130\u20131131.","journal-title":"Lancet"},{"key":"BFmp2013165_CR6","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000; 97: 8104\u20138109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR7","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1126\/science.2878495","volume":"234","author":"DF Wong","year":"1986","unstructured":"Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558\u20131563.","journal-title":"Science"},{"key":"BFmp2013165_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2008.30","volume":"14","author":"SJ Glatt","year":"2009","unstructured":"Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu HG, Tsuang MT . Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry 2009; 14: 885\u2013893.","journal-title":"Mol Psychiatry"},{"key":"BFmp2013165_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/sj.mp.4001321","volume":"8","author":"SJ Glatt","year":"2003","unstructured":"Glatt SJ, Faraone SV, Tsuang MT . Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003; 8: 911\u2013915.","journal-title":"Mol Psychiatry"},{"key":"BFmp2013165_CR10","doi-asserted-by":"publisher","first-page":"20552","DOI":"10.1073\/pnas.0707106104","volume":"104","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 2007; 104: 20552\u201320557.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR11","doi-asserted-by":"publisher","first-page":"e9348","DOI":"10.1371\/journal.pone.0009348","volume":"5","author":"A Bertolino","year":"2010","unstructured":"Bertolino A, Taurisano P, Pisciotta NM, Blasi G, Fazio L, Romano R et al. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS ONE\u00a02010; 5: e9348.","journal-title":"PLoS ONE"},{"key":"BFmp2013165_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/35041572","volume":"408","author":"A Usiello","year":"2000","unstructured":"Usiello A, Baik JH, Roug\u00e9-Pont F, Picetti R, Dierich A, LeMeur M et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000; 408: 199\u2013203.","journal-title":"Nature"},{"key":"BFmp2013165_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0169-328X(99)00343-5","volume":"76","author":"P Seeman","year":"2000","unstructured":"Seeman P, Nam D, Ulpian C, Liu IS, Tallerico T . New dopamine receptor, D2(Longer), with unique TG splice site, in human brain. Brain Res Mol Brain Res 2000; 76: 132\u2013141.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFmp2013165_CR14","doi-asserted-by":"publisher","first-page":"8776","DOI":"10.1073\/pnas.1432696100","volume":"100","author":"J Xie","year":"2003","unstructured":"Xie J, Lee JA, Kress TL, Mowry KL, Black DL . Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc Natl Acad Sci USA 2003; 100: 8776\u20138781.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1471-4159.2010.07086.x","volume":"116","author":"T Sasabe","year":"2011","unstructured":"Sasabe T, Futai E, Ishiura S . Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D(2). J Neurochem 2011; 116: 76\u201381.","journal-title":"J Neurochem"},{"key":"BFmp2013165_CR16","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1073\/pnas.95.13.7731","volume":"95","author":"ZU Khan","year":"1998","unstructured":"Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, Goldman-Rakic PS . Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 1998; 95: 7731\u20137736.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR17","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1073\/pnas.0730708100","volume":"100","author":"N Lindgren","year":"2003","unstructured":"Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P et al. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 2003; 100: 4305\u20134309.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/jcbfm.2011.194","volume":"32","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Yamada M, Suhara T . Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab 2012; 32: 1248\u20131258.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFmp2013165_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2011.08.069","volume":"1420","author":"F Zhu","year":"2011","unstructured":"Zhu F, Yan CX, Wang Q, Zhu YS, Zhao Y, Huang J et al. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Brain Res 2011; 1420: 106\u2013113.","journal-title":"Brain Res"},{"key":"BFmp2013165_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2202-13-18","volume":"13","author":"DA Rothmond","year":"2012","unstructured":"Rothmond DA, Weickert CS, Webster MJ . Developmental changes in human dopamine neurotransmission: cortical receptors and terminators. BMC Neurosci 2012; 13: 18.","journal-title":"BMC Neurosci"},{"key":"BFmp2013165_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","volume":"67","author":"A Nieoullon","year":"2002","unstructured":"Nieoullon A . Dopamine and the regulation of cognition and attention. Prog Neurobiol 2002; 67: 53\u201383.","journal-title":"Prog Neurobiol"},{"key":"BFmp2013165_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuint.2010.08.012","volume":"57","author":"T Morikawa","year":"2010","unstructured":"Morikawa T, Manabe T . Aberrant regulation of alternative pre-mRNA splicing in schizophrenia. Neurochem Int 2010; 57: 691\u2013704.","journal-title":"Neurochem Int"},{"key":"BFmp2013165_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.biopsych.2006.06.019","volume":"60","author":"BK Lipska","year":"2006","unstructured":"Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol Psychiatry 2006; 60: 650\u2013658.","journal-title":"Biol Psychiatry"},{"key":"BFmp2013165_CR24","doi-asserted-by":"crossref","unstructured":"Kunii Y, Hyde TM, Ye T, Li C, Kolachana B, Dickinson D et al. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry advance online publication, 8 January 2013; doi: 10.1038\/mp.2012.174 (e-pub ahead of print).","DOI":"10.1038\/mp.2012.174"},{"key":"BFmp2013165_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519\u2013523.","journal-title":"Nature"},{"key":"BFmp2013165_CR26","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/cercor\/bhq266","volume":"21","author":"A Rieckmann","year":"2011","unstructured":"Rieckmann A, Karlsson S, Karlsson P, Brehmer Y, Fischer H, Farde L et al. Dopamine D1 receptor associations within and between dopaminergic pathways in younger and elderly adults: links to cognitive performance. Cereb Cortex 2011; 21: 2023\u20132032.","journal-title":"Cereb Cortex"},{"key":"BFmp2013165_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.pnpbp.2010.02.003","volume":"34","author":"C Dubertret","year":"2010","unstructured":"Dubertret C, Bardel C, Ramoz N, Martin PM, Deybach JC, Ad\u00e8s J et al. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 492\u2013499.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2013165_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ng.171","volume":"40","author":"NC Allen","year":"2008","unstructured":"Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40: 827\u2013834.","journal-title":"Nat Genet"},{"key":"BFmp2013165_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","volume":"6","author":"T Arinami","year":"1997","unstructured":"Arinami T, Gao M, Hamaguchi H, Toru M . A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577\u2013582.","journal-title":"Hum Mol Genet"},{"key":"BFmp2013165_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/hmg\/ddg055","volume":"12","author":"J Duan","year":"2003","unstructured":"Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12: 205\u2013216.","journal-title":"Hum Mol Genet"},{"key":"BFmp2013165_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1126\/science.1825731","volume":"251","author":"T Sawaguchi","year":"1991","unstructured":"Sawaguchi T, Goldman-Rakic PS . D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947\u2013950.","journal-title":"Science"},{"key":"BFmp2013165_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0896-6273(04)00265-X","volume":"42","author":"NS Bamford","year":"2004","unstructured":"Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS et al. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004; 42: 653\u2013663.","journal-title":"Neuron"},{"key":"BFmp2013165_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2004.07.043","volume":"129","author":"D Centonze","year":"2004","unstructured":"Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E et al. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 2004; 129: 157\u2013166.","journal-title":"Neuroscience"},{"key":"BFmp2013165_CR34","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1046\/j.1471-4159.1995.65062706.x","volume":"65","author":"JQ Wang","year":"1995","unstructured":"Wang JQ, McGinty JF . Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif\/268 mRNA expression in rat forebrain. J Neurochem 1995; 65: 2706\u20132715.","journal-title":"J Neurochem"},{"key":"BFmp2013165_CR35","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1523\/JNEUROSCI.4178-03.2004","volume":"24","author":"AM Brady","year":"2004","unstructured":"Brady AM, O'Donnell P . Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 2004; 24: 1040\u20131049.","journal-title":"J Neurosci"},{"key":"BFmp2013165_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(94)90263-1","volume":"634","author":"P O'Donnell","year":"1994","unstructured":"O'Donnell P, Grace AA . Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 1994; 634: 105\u2013112.","journal-title":"Brain Res"},{"key":"BFmp2013165_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2008.12.002","volume":"9","author":"C De Mei","year":"2009","unstructured":"De Mei C, Ramos M, Iitaka C, Borrelli E . Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 2009; 9: 53\u201358.","journal-title":"Curr Opin Pharmacol"},{"key":"BFmp2013165_CR38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/sj.emboj.7601656","volume":"26","author":"FJ Lee","year":"2007","unstructured":"Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F . Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 2007; 26: 2127\u20132136.","journal-title":"EMBO J"},{"key":"BFmp2013165_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","volume":"122","author":"JM Beaulieu","year":"2005","unstructured":"Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG . An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122: 261\u2013273.","journal-title":"Cell"},{"key":"BFmp2013165_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","volume":"27","author":"JM Beaulieu","year":"2007","unstructured":"Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR et al. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007; 27: 881\u2013885.","journal-title":"J Neurosci"},{"key":"BFmp2013165_CR41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0026-895X(25)10202-2","volume":"45","author":"LJ Zhang","year":"1994","unstructured":"Zhang LJ, Lachowicz JE, Sibley DR . The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 1994; 45: 878\u2013889.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013165_CR42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1176\/ajp.156.10.1580","volume":"156","author":"M Akil","year":"1999","unstructured":"Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR et al. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 1999; 156: 1580\u20131589.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013165_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0169-328X(94)90296-8","volume":"25","author":"DA Roberts","year":"1994","unstructured":"Roberts DA, Balderson D, Pickering-Brown SM, Deakin JF, Owen F . The abundance of mRNA for dopamine D2 receptor isoforms in brain tissue from controls and schizophrenics. Brain Res Mol Brain Res 1994; 25: 173\u2013175.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFmp2013165_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archpsyc.1997.01830240045007","volume":"54","author":"JH Meador-Woodruff","year":"1997","unstructured":"Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ . Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry 1997; 54: 1089\u20131095.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2013165_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","volume":"206","author":"L Urig\u00fcen","year":"2009","unstructured":"Urig\u00fcen L, Garc\u00eda-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casad\u00f3 V et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology\u00a02009; 206: 313\u2013324.","journal-title":"Psychopharmacology"},{"key":"BFmp2013165_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2990.2010.01128.x","volume":"37","author":"L Zhan","year":"2011","unstructured":"Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B et al. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 2011; 37: 206\u2013219.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFmp2013165_CR47","unstructured":"Rothmond D, Akil M, Weickert C . Alterations in Dopamine d2 receptor isoform gene expression in the DLPFC of patients with schizophrenia. Annual Meeting for Society for Neuroscience 2010 40th Annual Meeting: Poster 326.316\/Z313."},{"key":"BFmp2013165_CR48","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0022-3565(25)11150-6","volume":"261","author":"A Janowsky","year":"1992","unstructured":"Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK . Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine. J Pharmacol Exp Ther 1992; 261: 1282\u20131290.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2013165_CR49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)36627-3","volume":"281","author":"MS Lidow","year":"1997","unstructured":"Lidow MS, Elsworth JD, Goldman-Rakic PS . Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther 1997; 281: 597\u2013603.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2013165_CR50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)37099-5","volume":"283","author":"MS Lidow","year":"1997","unstructured":"Lidow MS, Goldman-Rakic PS . Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther 1997; 283: 939\u2013946.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2013165_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02246947","volume":"110","author":"JE Leysen","year":"1993","unstructured":"Leysen JE, Gommeren W, Mertens J, Luyten WH, Pauwels PJ, Ewert M et al. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone. Psychopharmacology (Berl) 1993; 110: 27\u201336.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2013165_CR52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0026-895X(25)13652-3","volume":"43","author":"A Malmberg","year":"1993","unstructured":"Malmberg A, Jackson DM, Eriksson A, Mohell N . Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol 1993; 43: 749\u2013754.","journal-title":"Mol Pharmacol"},{"key":"BFmp2013165_CR53","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.mp.4001145","volume":"7","author":"R Xu","year":"2002","unstructured":"Xu R, Hranilovic D, Fetsko LA, Bucan M, Wang Y . Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry 2002; 7: 1075\u20131082.","journal-title":"Mol Psychiatry"},{"key":"BFmp2013165_CR54","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0269881111409265","volume":"26","author":"A Abi-Dargham","year":"2012","unstructured":"Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N et al. Increased prefrontal cortical D(1) receptors in drug naive patients with schizophrenia: a PET study with [(1)(1)C]NNC112. J Psychopharmacol 2012; 26: 794\u2013805.","journal-title":"J Psychopharmacol"},{"key":"BFmp2013165_CR55","doi-asserted-by":"publisher","first-page":"15873","DOI":"10.1073\/pnas.0903413106","volume":"106","author":"K Nakata","year":"2009","unstructured":"Nakata K, Lipska BK, Hyde TM, Ye T, Newburn EN, Morita Y et al. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 2009; 106: 15873\u201315878.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013165_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/hmg\/ddl449","volume":"16","author":"AJ Law","year":"2007","unstructured":"Law AJ, Kleinman JE, Weinberger DR, Weickert CS . Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007; 16: 129\u2013141.","journal-title":"Hum Mol Genet"},{"key":"BFmp2013165_CR57","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/sj.npp.1301669","volume":"33","author":"LJ Sartorius","year":"2008","unstructured":"Sartorius LJ, Weinberger DR, Hyde TM, Harrison PJ, Kleinman JE, Lipska BK . Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. Neuropsychopharmacology 2008; 33: 2626\u20132634.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2013165_CR58","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1523\/JNEUROSCI.4626-11.2012","volume":"32","author":"R Tao","year":"2012","unstructured":"Tao R, Li C, Newburn EN, Ye T, Lipska BK, Herman MM et al. Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci 2012; 32: 5216\u20135222.","journal-title":"J Neurosci"},{"key":"BFmp2013165_CR59","doi-asserted-by":"publisher","first-page":"e36351","DOI":"10.1371\/journal.pone.0036351","volume":"7","author":"JQ Wu","year":"2012","unstructured":"Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott RJ, Carr VJ et al. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS ONE\u00a02012; 7: e36351.","journal-title":"PLoS ONE"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2013165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:54:48Z","timestamp":1746071688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2013165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFmp2013165"],"URL":"https:\/\/doi.org\/10.1038\/mp.2013.165","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]},"assertion":[{"value":"6 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}